MedTrace Logo

Measurement of Mass Change in Serum Albumin Compared to Serum Lactic Acid as Predictive Tool for Sepsis Prognosis in Non Surgical ICU Patients

NCT07289906 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-12-17

No results posted yet for this study

Summary

This study aims to assess the reliability of measurement of mass change in serum albumin compared to serum lactic acid as predictive tool for sepsis prognosis in nonsurgical ICU patients

Conditions

  • Prognosis Prediction of Sepsis in Icu Patients

Interventions

DIAGNOSTIC_TEST

Mass change in serum albumin

study aims to assess the accuracy of measurement of mass change in serum albumin compared to serum lactic acid as predictive tool for sepsis prognosis in nonsurgical ICU patients

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Alaa E Mohamed Hassen, Prof · Department of anesthesia ,Intensive Care and pain management

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-28
Primary Completion
2026-09-28
Completion
2026-09-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07289906 on ClinicalTrials.gov